[Hot spots in cancer immunotherapy and status quo of vaccine research for lung cancer]
[Article in
Chinese]
Affiliations
- PMID: 24119897
Item in Clipboard
[Hot spots in cancer immunotherapy and status quo of vaccine research for lung cancer]
[Article in
Chinese]
Zhonghua Zhong Liu Za Zhi.
2013 Jun.
No abstract available
Similar articles
-
Immunotherapy for lung cancer.Proc Am Thorac Soc. 2009 Apr 15;6(2):224-32. doi: 10.1513/pats.200806-048LC. Proc Am Thorac Soc. 2009. PMID: 19349492 Review.
-
Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer.Lung Cancer. 2009 Jul;65(1):1-8. doi: 10.1016/j.lungcan.2008.10.018. Epub 2008 Dec 4. Lung Cancer. 2009. PMID: 19062127 Review.
-
Immunotherapy in lung cancer: "b7-bombers" and other new developments.Semin Respir Crit Care Med. 2013 Dec;34(6):810-21. doi: 10.1055/s-0033-1358551. Epub 2013 Nov 20. Semin Respir Crit Care Med. 2013. PMID: 24258571 Review.
-
The state of the art in non-small cell lung cancer immunotherapy.Semin Thorac Cardiovasc Surg. 2014 Spring;26(1):26-35. doi: 10.1053/j.semtcvs.2014.02.005. Epub 2014 Mar 26. Semin Thorac Cardiovasc Surg. 2014. PMID: 24952755 Review.
-
Harnessing the immune system for the treatment of non-small-cell lung cancer.J Clin Oncol. 2013 Mar 10;31(8):1021-8. doi: 10.1200/JCO.2012.45.8703. Epub 2013 Feb 11. J Clin Oncol. 2013. PMID: 23401435 Review.
Cited by
-
POU2F1 induces the immune escape in lung cancer by up-regulating PD-L1.Am J Transl Res. 2021 Feb 15;13(2):672-683. eCollection 2021. Am J Transl Res. 2021. PMID: 33594317 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
